相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lysosomal trapping of palbociclib and its functional implications
Susana Llanos et al.
ONCOGENE (2019)
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer
S. -A. Im et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Kinase-independent function of E-type cyclins in liver cancer
Yan Geng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins
Samrat T. Kundu et al.
NATURE COMMUNICATIONS (2018)
CDK4/6 inhibition in breast cancer: current practice and future directions
Sonia Pernas et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
Lysosomal metabolomics reveals V-ATPase- and mTOR-dependent regulation of amino acid efflux from lysosomes
Monther Abu-Remaileh et al.
SCIENCE (2017)
CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers
Smruthi Vijayaraghavan et al.
NATURE COMMUNICATIONS (2017)
Single-Cell Dynamics Determines Response to CDK4/6 Inhibition in Triple-Negative Breast Cancer
Uzma S. Asghar et al.
CLINICAL CANCER RESEARCH (2017)
CDK4 phosphorylation status and a linked gene expression profile predict sensitivity to palbociclib
Eric Raspe et al.
EMBO MOLECULAR MEDICINE (2017)
NeoPalAna: Neoadjuvant Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, and Anastrozole for Clinical Stage 2 or 3 Estrogen Receptor-Positive Breast Cancer
Cynthia X. Ma et al.
CLINICAL CANCER RESEARCH (2017)
Cell cycle proteins as promising targets in cancer therapy
Tobias Otto et al.
NATURE REVIEWS CANCER (2017)
Targeting CDK4 and CDK6: From Discovery to Therapy
Charles J. Sherr et al.
CANCER DISCOVERY (2016)
Phase I study of palbociclib, a cyclin-dependent kinase 4/6 inhibitor, in Japanese patients
Kenji Tamura et al.
CANCER SCIENCE (2016)
Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer
Shaokun Shu et al.
NATURE (2016)
Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR
Maximilian Haeussler et al.
GENOME BIOLOGY (2016)
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
Hui Gao et al.
NATURE MEDICINE (2015)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop
Carmine Settembre et al.
NATURE CELL BIOLOGY (2013)
The Requirement for Cyclin D Function in Tumor Maintenance
Yoon Jong Choi et al.
CANCER CELL (2012)
The Therapeutic Potential of Sigma (σ) Receptors for the Treatment of Central Nervous System Diseases: Evaluation of the Evidence
Samuel D. Banister et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection
Maurizio Renna et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
A Gene Network Regulating Lysosomal Biogenesis and Function
Marco Sardiello et al.
SCIENCE (2009)
Cell cycle, CDKs and cancer: a changing paradigm
Marcos Malumbres et al.
NATURE REVIEWS CANCER (2009)
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro
Richard S. Finn et al.
BREAST CANCER RESEARCH (2009)
Anti-cancer agent siramesine is a lysosomotropic detergent that induces cytoprotective autophagosome accumulation
Marie Stampe Ostenfeld et al.
AUTOPHAGY (2008)
Prodrugs: design and clinical applications
Jarkko Rautio et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas
Jason I. Herschkowitz et al.
BREAST CANCER RESEARCH (2008)
Requirement for CDK4 kinase function in breast cancer
QY Yu et al.
CANCER CELL (2006)
Cyclin D1 in breast cancer pathogenesis
A Arnold et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cyclins and cdks in development and cancer: a perspective
A Deshpande et al.
ONCOGENE (2005)
Proliferation of cancer cells despite CDK2 inhibition
O Tetsu et al.
CANCER CELL (2003)
Sibling rivalry in the E2F family
JM Trimarchi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Specific protection against breast cancers by cyclin D1 ablation
QY Yu et al.
NATURE (2001)
A chemical switch for inhibitor-sensitive alleles of any protein kinase
AC Bishop et al.
NATURE (2000)
分享论文
